Avalo Therapeutics (AVTX) Receivables (2016 - 2023)
Avalo Therapeutics (AVTX) recorded Receivables of $44,000 in Q2 2023, down 98.0% from $2.21 million a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Receivables (2016 - 2023) Analysis & Trends
At the end of FY2022, Avalo Therapeutics reported Receivables of $1.92 million, down 60.0% from FY2021.
- Annual Receivables has a five-year compound annual growth rate of -8.1% (FY2017 to FY2022).
- Across earlier years, Receivables came in at $4.8 million in FY2021 (+9.4%), $4.39 million in FY2020 (-16.4%), $5.24 million in FY2019 (-13.8%) and $6.08 million in FY2018 (+107.3%).
- The Q2 2023 figure is the lowest quarterly Receivables in data going back to Q4 2016.
- On a year-over-year basis, Receivables rose in 1 of the last seven quarters, with an average decline of 48.5%.
- Peak year-over-year performance for Receivables in the last five years was growth of 107.3% in Q4 2018, against a decline of 98.0% in Q2 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Avalo Therapeutics | 533.82 Mn | -158.40 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 44,000.00 |
| Dec 31, 2022 | 1.92 Mn |
| Sep 30, 2022 | 2.11 Mn |
| Jun 30, 2022 | 2.21 Mn |
| Mar 31, 2022 | 2.38 Mn |
| Dec 31, 2021 | 4.80 Mn |
| Sep 30, 2021 | 3.91 Mn |
| Jun 30, 2021 | 5.12 Mn |
| Mar 31, 2021 | 5.19 Mn |
| Dec 31, 2020 | 4.39 Mn |
| Sep 30, 2020 | 5.96 Mn |
| Jun 30, 2020 | 3.98 Mn |
| Mar 31, 2020 | 4.26 Mn |
| Dec 31, 2019 | 5.24 Mn |
| Sep 30, 2019 | 4.96 Mn |
| Jun 30, 2019 | 2.86 Mn |
| Mar 31, 2019 | 2.72 Mn |
| Dec 31, 2018 | 6.08 Mn |
| Sep 30, 2018 | 3.01 Mn |
| Jun 30, 2018 | 3.31 Mn |
API Access
Avalo Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();